Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
05/2003
05/07/2003EP0781165B1 Improved high performance vpo catalyst
05/07/2003EP0751765B1 Sulfonamide derivatives and their use
05/07/2003EP0749433B1 (4,4-difluorobut-3-enylthio)-substituted heterocyclic or carbocyclic ring compounds having pesticidal activity
05/07/2003CN1416427A Method for producing maleic acid anhydride
05/07/2003CN1416367A Hollow cylindrical catalyst and method for producing maleic acid anhydride
05/07/2003CN1415619A Compound for adjusting functional activity of vascular endothelial cell, its preparation method as well as usage
05/07/2003CN1415617A Compound possessing function for preventing and curing atherosclerosis and its application in biologic pharmacological science
05/06/2003US6559347 Diels-adler adducts of epoxybutene and epoxybutene derivatives
05/06/2003US6559341 Phthalic acid diamide derivatives, fluorine-containing aniline compounds as starting material, agricultural and horticultural insecticides, and a method for application of the insecticides
05/06/2003US6559185 Nitromethyl ketone compounds having aldose reduction inhibiting properties and methods for their use
05/06/2003US6559176 A method for regulating the activity of an autoinducer-2 receptor comprising contacting an autoinducer-2 receptor with an AI-2 agonist or antagonist compound.
05/06/2003US6559137 Characterized by favorable aqueous solubility, high oral bioavailability and facile in vivo generation of the active ingredient
05/06/2003US6559100 2-benzoyl-cyclohexane-1,3-diones
05/06/2003CA2244194C Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
05/02/2003EP1305305A1 Hyperpolarizable organic chromophores
05/02/2003EP1305304A1 Carboxamide compounds and their use as antagonists of a human 11cby receptor
05/02/2003EP1305292A1 Biphenyl carboxamides
05/02/2003EP1305028A2 Antimicrobial biaryl compounds
05/02/2003EP1117484B1 Multilayered shell catalysts for catalytic gaseous phase oxidation of aromatic hydrocarbons
05/02/2003EP1105381B1 Dibenzothiophene compounds and methods of use thereof
05/02/2003EP0901482B1 Benzofuran carboxamides and their therapeutic use
05/02/2003EP0772593B1 Thiopyridyl compounds for controlling helicobacter bacteria
05/01/2003WO2003035714A1 Triarylamine containing monomers for optoelectronic devices
05/01/2003WO2003035627A1 Piperazine derivatives with ccr1 receptor antagonist activity
05/01/2003WO2003035620A1 Bicyclic compound
05/01/2003WO2003035057A1 Inhibitors of dipeptidyl peptidase iv
05/01/2003WO2003034989A2 α-HYDROXYARYLBUTANAMINE INHIBITORS OF ASPARTYL PROTEASE
05/01/2003WO2003006443A3 2- 4-(naphtalin-2-yl)-thiazol-2-ylaminocarbonyl benzoic acid and 2- 4-(naphtalin-2-yl)-pyrimidin-2-ylaminocarbonyl benzoic acid and additional compounds serving as telomerase inhibitors for use in tumor therapy
05/01/2003WO2002048165A3 Antiviral agents for treatment of flaviviridae infections
05/01/2003WO2002005834A3 Novel uses for thyroid hormones or thyroid hormone-like agonist compounds for treating dermis conditions
05/01/2003US20030083529 Process for producing vinyl ether compounds
05/01/2003US20030083523 Amide derivatives
05/01/2003US20030083522 Anhydride stabilization
05/01/2003US20030083521 Such as 5-phenyl-2,4-pentadienoylhydroxamic acid; for treating cancer, hematopoiesis, and genetic metabolic disorders (cystic fibrosis and adrenoleukodystrophy)
05/01/2003US20030083509 Stepwise alkylation of 5-substituted 1-(4-fluorophenyl)-1,3-dihydroisobenzofurans
05/01/2003US20030083508 Method for the preparation of citalopram
05/01/2003US20030083505 Benzenedicarboxylic acid derivatives
05/01/2003US20030083504 N- (4-carbamimidoyl-phenyl) -glycine derivatives
05/01/2003US20030083382 Orally administered dosage forms of GABA analog prodrugs having reduced toxicity
05/01/2003US20030083362 Synthesis and antimicrobial activity of novel dicationic"reversed amidines"
05/01/2003US20030083357 Oxime derivatives for the treatment of dyslipidemia and hypercholesteremia
05/01/2003US20030083341 2,3,5-Substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia
05/01/2003US20030083331 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
05/01/2003US20030082830 Compound for use as diagnostic and therapeutic tools in medicine and science
05/01/2003US20030082631 Detecting modulator of peroxisome proliferator-activated receptor; obtain sample contain proxisome receptor, incubate with test agent, monitor sample for adjustment in receptor activity
05/01/2003US20030080320 Combining a tertiary amide with a pentavalent phosphorous halide in a solvent to form an alpha - haloiminium salt and converting the alpha -haloiminium salt to the alpha -haloenamine with a base
05/01/2003CA2464254A1 Inhibitors of post-proline cleaving proteases
04/2003
04/30/2003CN1414963A Novel heteroary derivatives, their preparation and use
04/30/2003CN1414934A Process for co-production of aliphatic dihydric alcohol and cyclic ethers
04/30/2003CN1414849A Carboxylic acid amides, medicaments containing these compounds and the use and preparation thereof
04/30/2003CN1107061C Chemotaxis cell factor receptor-3 receptor antagonists
04/30/2003CN1107049C Benzyloxy substituted aromatics and their use as fungicides and insecticides
04/29/2003US6555697 Method of preparing a benzofuran or benzothiophene compound
04/29/2003US6555580 Treating arteriosclerosis and hypercholesterolaemia
04/29/2003US6555577 Compounds, their preparation and use
04/29/2003US6555566 Methods and materials for treating and preventing inflammation of mucosal tissue
04/29/2003US6555561 Diaminopyridine-containing thiourea inhibitors of herpes viruses
04/29/2003US6555559 5,6,7-trinor-4,8-inter-m-phenylene PGI2, derivative and drugs containing the same
04/29/2003US6555537 Piperazine derivatives and their use as anti-inflammatory agents
04/29/2003US6555356 Methods for microbial regulation
04/24/2003WO2003033484A1 Substituted piperazine cyclohexane carboxilic acid amides and the use thereof
04/24/2003WO2003033483A1 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors
04/24/2003WO2003033467A1 Nitroso diphenylamine derivatives as nitrogen monoxide generating agents
04/24/2003WO2003033457A1 Biphenyl-derivatives as p38-kinase inhibitors
04/24/2003WO2003033448A1 Method for isolating salts of organic acids from a fermentation broth and for releasing the organic acid
04/24/2003WO2003032980A1 5'-carbamoyl-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors
04/24/2003WO2003032978A1 Pharmaceutical compositions comprising mycophenolic acid or mycophenolate salt
04/24/2003WO2003032971A1 5’-acylamino-1,1’-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors
04/24/2003WO2003032970A1 5'-carbamoyl-2'-methyl-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors
04/24/2003WO2002102756A3 Polyimides comprising cf2o structural elements
04/24/2003WO2002100437A3 Ophthalmic compositions comprising hyaluronic acid
04/24/2003WO2002098850A3 Chemical compounds and pharmaceutical compositions as cathepsin s inhibitors
04/24/2003WO2002058690A3 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors
04/24/2003US20030078444 Fluorous triphase and ther multiphase systems for effecting reactions and/or separation
04/24/2003US20030078442 Crystalline base of citalopram
04/24/2003US20030078428 Phenylamino benzhydroxamic acid derivatives inhibit certain dual specificity kinase enzymes involved in proliferative diseases such as cancer, psoriasis and restenosis; inhibit the phosphorylation of MAP kinase by MEK
04/24/2003US20030078418 Useful potentiators of beta -lactam antibiotics; therapy
04/24/2003US20030078287 For controlling plant and animal pests
04/24/2003US20030078266 Powder of 30-90% a water-soluble cycloxygenase inhibitor, 5-60% of a buffer and 0-10% of other excipients
04/24/2003US20030078264 Treating atherosclerosis and other coronary artery diseases
04/24/2003US20030078261 Prostaglandin agonists
04/24/2003US20030078250 Diphenyl urea compounds for treating a chemokine mediated disease; interleukin-8 (il-8)
04/24/2003US20030078249 VLA-4 inhibitor compounds
04/24/2003US20030078239 Ketone compounds and compositions for cholesterol management and related uses
04/24/2003US20030078235 Treatment of central nervous system disorders; anticonvulsants, antiepileptics, neuroprotective agents and muscle relaxants
04/24/2003CA2463426A1 Substituted piperazine cyclohexane carboxilic acid amides and the use thereof
04/24/2003CA2460574A1 Enteric coated tablets comprising mycophenolic acid or mycophenolate salt
04/23/2003EP1304328A1 Process for the preparation of a benzofuran derivative
04/23/2003EP1303580A1 Marine oils with reduced levels of contaminants
04/23/2003EP1303520A1 Therapeutic compounds and methods
04/23/2003EP1303509A1 Beta3 adrenergic agonists
04/23/2003EP1303503A2 Aniline derivatives
04/23/2003EP1303483A1 Novel thiourea derivatives and the pharmaceutical compositions containing the same
04/23/2003EP1303479A2 7-, 8- and 9-substituted tetracycline compounds
04/23/2003EP1303478A1 Process for the preparation of substituted octanoyl amides
04/23/2003EP1303308A2 Aldosterone antagonist and cyclooxygenase-2 inhibitor combination therapy to prevent or treat inflammation-related cardiovascular disorders
04/23/2003EP1303271A1 Ophthalmic formulation of a selective cyclooxygenase-2 inhibitory drug
04/23/2003EP1185494B1 Method of gas phase catalytic oxidation to give maleic acid anhydride
04/23/2003EP1137596B1 Polymetal oxide containing silver oxide and vanadium oxide and the use thereof
04/23/2003EP1048662B1 Novel process for producing 3-hydroxy-gamma-butyrolactone derivatives
1 ... 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 ... 472